Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsUs fda approval

    Us Fda Approval

    Jump to

    • Stocks to Watch Today: Biocon, Coforge, GE Vernova, Power Grid

      Biocon Pharma has received US FDA approvals for Lenalidomide capsules and Dasatinib tablets, with tentative approval for Rivaroxaban tablets. Coforge has partnered with Sabre Corporation to accelerate product delivery and launch AI solutions. Adani Wilmar is acquiring 80% of GD Foods' 'Tops' brand in a multi-tranche deal. Ola Electric is addressing IFCI’s concerns over Milestone-1 non-achievement while engaging with authorities and progressing on its PLI ACC scheme agreement. GE Vernova T&D India has secured Rs 500 crore orders from Power Grid Corporation of India for transformers and reactors.

    • Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients

      The approval by the US Food and Drug Administration (USFDA) is to manufacture and market Isosorbide Mononitrate Extended-Release, of strengths 30 mg, 60 mg, and 120 mg, Zydus Lifesciences said in a regulatory filing.

    • Lupin gets USFDA nod to market generic medication in US

      The company's Somerset-based wholly-owned subsidiary Lupin Inc has received approval from the US Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets, Lupin said in a statement.

    • What is Mifepristone and why is it being banned in the US?

      The Biden administration has seven days to appeal to the 5th US Circuit Court of Appeals.

    • Sun Pharma gets US FDA nod for Riluzole 50mg tablets

      Riluzole is used to treat amyotrophic lateral sclerosis. Sun Pharma had received tentative approval for the drug from US FDA in 2010.

    • Quick review of pharma sector: UR Associates

      UR Associates has come out with its report on pharma sector. As per the research firm, Indian pharma companies are expected to make a good use of the above mentioned opportunities although they might not provide significant one time upside for them.

    • Ipca Labs hopes to achieve 18-20% growth for FY12

      AK Jain, the executive director of Ipca Labs, in an interview on CNBC-TV18, talks about the latest happenings in the company and sector.

    • Jubilant Life receives US FDA approval for tablets

      Jubilant Life Sciences has received US FDA approval for Donepezil Hydrochloride tablets 5mg & 10 mg, reports CNBC-TV18. It touched an intraday high of Rs 169.45 and an intraday low of Rs 163. At 10:14 hrs the share was quoting at Rs 165.90, up Rs 5.15, or 3.20%.

    • Strides Arcolab's oncology unit gets US FDA nod

      Pharma firm Strides Arcolab said on Monday its unit received the US FDA's approval for a new oncology facility in Bangalore that would help the company commercialise its first product in the US after June, sending its shares up over 2%.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347